How does the data from EHA change clinical practice in multiple myeloma?


Learning objective:

After participating in this webinar, viewers should be able to:

  • Evaluate how recent data updates may impact the clinical management of patients with multiple myeloma
  • Discuss the potential role of cellular therapies in the management of patients with multiple myeloma



15.00-15.05 Introduction – Scott Miller & Martin Vogel
15.05-15.25 Update on data regarding management of newly-diagnosed MM (transplant eligible and transplant ineligible) including early relapse - Philippe Moreau
15.25-15.45 Discussion
15.45-16.05 Highlights relating to management of patients with multiple relapses or refractory MM, including cellular therapies – Noopur Raje
16.05-16.25 Discussion
16.25-16.30 Close


  • Scott Miller (Janssen)
  • Martin Vogel (Janssen)



  • Philippe Moreau (France)
  • Noopur Raje (USA)

More Info
91 Minutes